In consultation: Guidance and quality standards
Showing 1 to 4 of 4
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Falls: assessment and prevention in older people and people 50 and over at higher risk (update) | Draft guidance consultation | NICE guideline | |
Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130] | Evaluation consultation | Highly specialised technology | |
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222] | Draft guidance | Technology appraisal guidance | |
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer [ID6328] | Draft guidance | Technology appraisal guidance |